🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Massachusetts › Worcester

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Worcester, MA

Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Worcester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2
  • UMass Memorial Medical Center - University Campus, Worcester
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05564390

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Nagre-recruitPhase 3
  • UMass Memorial Medical Center - University Campus, Worcester
6 Months – 21 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04293562

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3
  • University of Massachusetts, Worcester
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Nagre-recruitObservasyonal na pag-aaral
  • Dana Farber Cancer Institute at Milford Regional Medical Center, Milford · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT02269592

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1
  • UMass Chan Medical School, Worcester
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Worcester

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.